Laman UtamaALKS • NASDAQ
add
Alkermes Plc
Tutup sebelumnya
$28.42
Julat hari
$27.90 - $28.46
Julat tahun
$22.90 - $32.88
Permodalan pasaran
4.54B USD
Bilangan Purata
1.51J
Nisbah P/E
14.32
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 378.14J | -0.73% |
Perbelanjaan pengendalian | 210.29J | -8.67% |
Pendapatan bersih | 92.38J | 93.44% |
Margin untung bersih | 24.43 | 94.82% |
Pendapatan bagi setiap syer | 0.73 | 14.06% |
EBITDA | 111.73J | 3.59% |
Kadar cukai berkesan | 15.82% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 908.86J | 2.22% |
Jumlah aset | 2.16B | -5.44% |
Jumlah liabiliti | 863.18J | -6.55% |
Jumlah ekuiti | 1.29B | — |
Syer tertunggak | 161.80J | — |
Harga kepada buku | 3.56 | — |
Pulangan pada aset | 12.01% | — |
Pulangan pada modal | 15.82% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 92.38J | 93.44% |
Tunai daripada operasi | 81.59J | -18.17% |
Tunai daripada pelaburan | -109.33J | 8.40% |
Tunai daripada pembiayaan | -111.11J | -7,190.87% |
Perubahan bersih dalam tunai | -138.86J | -667.84% |
Aliran tunai bebas | 31.74J | -63.37% |
Perihal
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Diasaskan
1987
Tapak web
Pekerja
2,100
